SteelPeak Wealth’s Biogen BIIB Stock Holding History

SteelPeak Wealth’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$651K	Buy	3,011 +307	+11%	+$58.7K	0.02%	385
2026 Q1	$496K	Buy	+2,704	New	+$498K	0.02%	379
2022 Q4	–	Sell	-1,066	Closed	-$285K	–	422
2022 Q3	$285K	Sell	1,066 -243	-19%	-$51.6K	0.02%	329
2022 Q2	$267K	Buy	1,309 +11	+0.8%	+$2.25K	0.02%	334
2022 Q1	$273K	Buy	+1,298	New	+$282K	0.02%	361
2021 Q4	–	Sell	-5,017	Closed	-$1.42M	–	426
2021 Q3	$1.42M	Buy	5,017 +4,411	+728%	+$1.45M	0.09%	130
2021 Q2	$210K	Buy	+606	New	+$184K	0.01%	386
2020 Q3	–	Sell	-12,079	Closed	-$3.23M	–	297
2020 Q2	$3.23M	Buy	+12,079	New	+$3.63M	0.41%	59

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SteelPeak Wealth's BIIB Position: Q2 2026 in Review

SteelPeak Wealth increased its Biogen (BIIB) stake by 11% in Q2 2026, buying an estimated $58.7K and bringing the position to 3,011 shares worth $651K. The position accounts for 0.02% of the portfolio, ranked #385.

SteelPeak Wealth first reported a position in BIIB in Q2 2020 and has held it in 8 quarters since. The position peaked at $3.23M in Q2 2020. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

SteelPeak Wealth held 3,011 shares of Biogen worth $651K as of Q2 2026.
SteelPeak Wealth bought 307 Biogen shares in Q2 2026, an estimated $58.7K.
Biogen made up 0.02% of SteelPeak Wealth's portfolio in Q2 2026, its #385 holding.
SteelPeak Wealth first reported a position in Biogen in Q2 2020 and has held it in 8 quarters since.
SteelPeak Wealth's Biogen position peaked at $3.23M in Q2 2020.
1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on SteelPeak Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.